Plerixafor
In Stock•Starting at $8 for 1 mg•Purity ≥ 99%
| CAS No. | 110078-46-1 |
|---|---|
| MDL No. | MFCD05662218 |
| MF | C28H54N8 |
| MW | 502.80 |
| InChI Key | YIQPUIGJQJDJOS-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $8 | In Stock | |
| 10 mg | 99% | $20 | In Stock | |
| 50 mg | 99% | $41 | In Stock | |
| 100 mg | 99% | $61 | In Stock | |
| 250 mg | 99% | $98 | In Stock |
Product Information
Plerixafor is an azamacrocycle composed of two cyclam rings linked by a 1,4-phenylenebis(methylene) bridge. It functions as a CXCR4 chemokine receptor antagonist and hematopoietic stem cell mobilizer. Used in combination with G-CSF, it mobilizes hematopoietic stem cells into peripheral blood for collection and autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma. It serves as an immunological adjuvant, antineoplastic agent, anti-HIV agent, and C-X-C chemokine receptor type 4 antagonist. It is classified as an azamacrocycle, crown amine, secondary amino compound, azacycloalkane, tertiary amino compound, and member of benzenes. Functionally related to 1,4,8,11-tetraazacyclotetradecane.
| CAS No. | 110078-46-1 |
|---|---|
| Product Name | Plerixafor |
Biological Targets
CXCR4
Associated Conditions
lymphopenia·chronic liver failure·chronic lymphocytic leukemia·childhood acute lymphoblastic leukemia·blood platelet disease·
* The information provided here is compiled from public sources and is for reference only.
